IL-1-blocking therapy in colchicine-resistant familial Mediterranean fever

Kucuksahin O, et al.

Clin Exp Rheumatol · 2018

Grade Bcohort

Key Findings

  • Rapid (2-3 days) and persistent suppression of FMF symptoms
  • Significant reduction in attack frequency (P<0.003)
  • Well tolerated over median 2 years

Referenced in (1 disease)

ID: pmid-30418119PMID: 30418119